Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients

Fig. 2

Time course for eGFR changes according to baseline eGFR. Baseline eGFR is divided into the three groups of ≥90 mL/min/1.73 m2 (Group H: high eGFR, n = 6), ≥60 but < 90 mL/min/1.73 m2 (Group M: middle eGFR, n = 26), and ≥ 45 but < 60 mL/min/1.73 m2 (Group L: low eGFR, n = 8). Changes in eGFR over time show no significant differences among these three groups

Back to article page